Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.


Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 16
Average round size
The average size of a deal this fund participated in
Portfolio companies 14
Rounds per year 1.45
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • SaaS
  • Software
  • Information Technology
  • Health Care
  • Artificial Intelligence

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of JobsOhio:
Typical Co-investors
JobsOhio is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after JobsOhio:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Assertive Investment -
BWB Ventures California, Los Angeles, United States
Canji Jiaye Touzi China, Guangdong, Shenzhen
Constellation Brands Canada Canada, Mississauga, Ontario
Envision Capital Management California, Los Angeles, United States
Fengwang Investment China, Shanghai
Flywheel Fund Bloomington, Indiana, United States
Jennings Capital Inc Alberta, Calgary, Canada
KOEI TECMO HOLDINGS Japan, Kanagawa Prefecture, Yokohama
Madison Paige Capital New York, New York, United States
Media Future Japan, Tokyo
Microsoft Climate Innovation Fund -
NAV.VC Reston, United States, Virginia
Referentia Systems Incorporated Hawaii, Honolulu, United States
Sun On Investment China, Guangdong, Guangzhou
TCR Capital France, Ile-de-France, Paris
Vignette Austin, Texas, United States
Wille Finance Switzerland, Zürich, Zurich
Yinbaodian Chuangtou China, Ningbo, Zhejiang
Zhidao Capital China, Jiangsu, Suzhou

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Centerline Biomedical

Health Care
$33M27 Jun 2022 Cleveland, Ohio, United States

SHARE Mobility

Autonomous Vehicles
Fleet Management
Ride Sharing
Smart Cities
$12M21 Jun 2022 Columbus, Ohio, United States

XII Medical

Health Care
Medical Device
$30M05 May 2022 Union City, California, United States


Health Care
$9M07 Mar 2022 Richfield, Ohio, United States


Artificial Intelligence
Big Data
Information Technology
Machine Learning
Predictive Analytics
$25M04 Jan 2022 Sunnyvale, California, United States

Valley Foods

Food Delivery
Service Industry
$1M08 Nov 2021 Youngstown, Ohio, United States


Artificial Intelligence
Business Intelligence
Cyber Security
Enterprise Software
Risk Management
$60M13 Oct 2021 Columbus, Ohio, United States

Eikonoklastes Therapeutics

Life Science
$3M06 May 2021 Cincinnati, Ohio, United States


Data Integration
Information Technology
01 May 2021 Columbus, Ohio, United States
Eikonoklastes Closes Series A Funding

– Eikonoklastes Therapeutics from Cincinnati, Ohio develops immunotherapies to treat a broad range of cancers beginning with Triple Negative Breast Cancer (TNBC), a lethal form of breast cancer that comprises 15% of all breast cancers.
– The company raised an undisclosed amount in Series A funding.
– The round was led by CincyTech with participation from New York-based Elk Capital Ventures, Jobs Ohio, Rev1, and other undisclosed investors.
– The new investment will be used to conduct Investigational New Drug (IND) enabling studies for Eikonoklastes Therapeutics’ L-ICON3 immune conjugate platform.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent JobsOhio?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: